Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1626
This examiner grants 61% of resolved cases
Jalisa Holmes Ferguson serves in Tech Center 1600 and Art Unit 1626, with 36 resolved cases. Her allowance rate is 61.1 percent. This rate indicates a moderate to high likelihood of success for applicants in her art unit. The 61.1 percent allowance rate suggests that the examiner is receptive to well-supported patent applications in the biotechnology and organic fields.
The interview lift is 43.8 percent. This is a very high lift, suggesting that interviews are an exceptionally effective strategy for securing an allowance. Given the 61.1 percent allowance rate, conducting an interview can significantly boost the chances of a positive outcome. For the 36 resolved cases, the 43.8 percent lift is a critical data point for practitioners to consider when planning their strategy.
The median days to allowance is 1208. This timeline reflects the typical duration for cases that reach a grant. With 36 resolved cases, the data highlights the importance of the 43.8 percent interview lift as a key strategic tool. The 1208-day median provides a realistic expectation for the time required to achieve a patent grant under this examiner.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18344134 | KRAS G12C INHIBITOR DOSING REGIMENS | Non-Final OA | Eli Lilly and Company |
| 18833568 | LYSOPHOSPHATIDYLSERINE ANALOGUE, AND LYSOPHOSPHATIDYLSERINE ANALOGUE-CONTAINING PHAMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING FIBROSIS | Non-Final OA | THE UNIVERSITY OF TOKYO |
| 18550326 | Methods For Treatment of Vitiligo | Non-Final OA | Pfizer Inc. |
| 18844371 | PYRIDO[1,2-A]PYRIMIDIN-4-ONE DERIVATIVES | Non-Final OA | Hoffmann-La Roche Inc. |
| 18550306 | HETEROARYL INHIBITORS OF PLASMA KALLIKREIN | Non-Final OA | TAKEDA PHARMACEUTICAL COMPANY LIMITED |
| 17916760 | COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF PREPARING COMPOUNDS AND OF THEIR USE | Non-Final OA | Repare Therapeutics Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy